NR3C2 and glomerulosclerosis: MR antagonism increases CuZn-SOD and Mn-SOD, alleviates glomerulosclerosis and proteinuria, and decreases renal (pro)renin receptor protein expression, angiotensinogen levels, AT1 receptor mRNA levels, and kidney Ang II content [335].